Natera is trading 5.51% up in pre-market at $436.10 on October 1, versus its September 30 close of $413.31, with no clearly confirmed fresh catalyst. - The move follows several sessions of relatively modest changes. - Recent favorable coverage includes Signatera’s Japan regulatory approval and analyst price-target increases, but both predate this session; available market coverage points to continued momentum, not a new event. - Broad market indications are mixed and do not clearly explain the gain.